Literature DB >> 23143993

Effects of glutamine supplementation on muscle function and stress responses in a mouse model of spinal cord injury.

Carissa Chamney1, Michelle Godar, Ethan Garrigan, Kimberly A Huey.   

Abstract

Spinal cord injury (SCI) results in loss of muscle function due to rapid breakdown of contractile proteins. Glutamine supplementation improves clinical outcomes, but its effects on muscle function after SCI are unknown. The benefits of glutamine in non-skeletal muscle tissues involve elevated heat shock protein (Hsp)70 and Hsp25, but the muscle response may differ because it is the largest contributor to plasma glutamine. We tested the hypothesis that glutamine preserves muscle function after SCI and that this is associated with increased heat shock protein and reduced inflammatory factors, interleukin-6 (IL-6) and tumour necrosis factor-α (TNFα). Changes in plantarflexor force, fatigability and total myofibrillar, Hsp70, Hsp25, IL-6 and TNFα muscle protein levels were measured 7 days after sham or spinal cord transection surgery in mice receiving daily placebo or glutamine. Compared with placebo, after SCI glutamine significantly attenuated the reductions in maximal isometric force (0.22 ± 0.01 versus 0.31 ± 0.03 N, respectively) and fatigue resistance (34 ± 4 versus 59 ± 4% of initial force, respectively). Glutamine significantly ameliorated the loss of myofibrillar protein with spinal cord transection. Spinal cord transection was associated with decreased Hsp70 and Hsp25 with glutamine only (45 ± 3 and 44 ± 5% of placebo, respectively). Glutamine significantly reduced spinal cord transection-associated increases in IL-6 and TNFα compared with placebo (38 ± 6 and 37 ± 8% of placebo, respectively). Functionally, early reductions in contractile protein, force and fatigue resistance after SCI were reversed with glutamine. Spinal cord transection-associated reductions in Hsp70, Hsp25, IL-6 and TNFα with glutamine versus placebo suggest lower stress in the muscle, possibly related to a reduced need to produce glutamine. These findings support glutamine as a therapeutic intervention to accelerate recovery of muscle function after SCI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143993     DOI: 10.1113/expphysiol.2012.069658

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  6 in total

1.  Glutamine synthetase in avian muscle contributes to a positive myogenic response to ammonia compared with mammalian muscle.

Authors:  Rachel Allysa Stern; Paul E Mozdziak
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-08       Impact factor: 3.619

2.  Glutamine supplementation improves contractile function of regenerating soleus muscles from rats.

Authors:  Tatiana E Koike; Rodrigo A Dell Aquila; Kellana S Silva; Marcelo S Aoki; Elen H Miyabara
Journal:  J Muscle Res Cell Motil       Date:  2022-02-24       Impact factor: 3.352

3.  Effect of glutamine enriched nutrition support on surgical patients with gastrointestinal tumor: a meta-analysis of randomized controlled trials.

Authors:  Kai Kang; Xiao-Liang Shu; Yong-Sheng Zhang; Xian-Li Liu; Jian Zhao
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

Review 4.  Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship.

Authors:  Xin Sun; Zachary B Jones; Xiao-Ming Chen; Libing Zhou; Kwok-Fai So; Yi Ren
Journal:  J Neuroinflammation       Date:  2016-10-06       Impact factor: 8.322

5.  TCA cycle rewiring fosters metabolic adaptation to oxygen restriction in skeletal muscle from rodents and humans.

Authors:  Daniele Capitanio; Chiara Fania; Enrica Torretta; Agnese Viganò; Manuela Moriggi; Valentina Bravatà; Anna Caretti; Denny Z H Levett; Michael P W Grocott; Michele Samaja; Paolo Cerretelli; Cecilia Gelfi
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

6.  Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats.

Authors:  Mojtaba Karimipour; Morteza Hassanzadeh; Masoumeh Zirak Javanmard; Gholamhossein Farjah
Journal:  Iran J Basic Med Sci       Date:  2018-08       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.